Medicine and Dentistry
Patient
100%
Lymphoma
40%
Cohort Analysis
34%
Therapeutic Procedure
32%
Survival
28%
Diffuse Large B-Cell Lymphoma
28%
Spontaneous Remission
27%
Inpatient
20%
Non-Hodgkin Lymphoma
17%
Overall Survival
17%
Follow up
16%
Acute Myeloid Leukemia
16%
Age
15%
Combination Therapy
15%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
12%
Hodgkin's Lymphoma
12%
COVID-19
11%
Mortality
11%
Adult
11%
Incidence
10%
International Prognostic Index
10%
Evaluation Study
9%
Diseases
9%
Relapse
9%
Oncology
9%
Lifespan
8%
Burkitt's Lymphoma
8%
Population
8%
Hospital
8%
Hazard Ratio
8%
Infection
7%
Bone Density
7%
Peripheral T-Cell Lymphoma
7%
Reproductive Medicine
7%
Prophylaxis
7%
B-Cell Lymphoma
7%
Second Cancer
7%
Retrospective Cohort Study
7%
Progression Free Survival
7%
Diagnosis
7%
Malignant Neoplasm
7%
Male
7%
Childbirth
7%
Psychoactive Drug
6%
Clinical Trial
6%
Death
6%
Gene
5%
Complication
5%
Female
5%
Myelodysplastic Syndrome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lymphoma
26%
Cohort Study
25%
Survival
17%
Nonhodgkin Lymphoma
13%
Acute Myeloid Leukemia
12%
Psychotropic Agent
10%
Myelodysplastic Syndrome
8%
Incidence
8%
Diffuse Large B Cell Lymphoma
7%
Second Cancer
7%
Mineral
7%
Chemotherapy
7%
Malignant Neoplasm
5%
Mortality
5%
Depression
5%
Nursing and Health Professions
Lymphoma
9%
Cohort Analysis
8%
Patient
7%
Phototherapy
7%
Evaluation Study
7%
B Cell Lymphoma
7%
Bilirubin
5%
